Picture of Castle Biosciences logo

CSTL — Castle Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Castle Biosciences Announces Third Quarter 2022 Results

Nov 2 (Reuters) - Castle Biosciences Inc  CSTL.O :
    * CASTLE BIOSCIENCES ANNOUNCES THIRD QUARTER 2022 RESULTS
    * SEES FY REVENUE $255.0 MILLION TO $330.0 MILLION
    * QTRLY REVENUES WERE $37.0 MILLION, A 58% INCREASE COMPARED
TO
$23.5 MILLION DURING SAME PERIOD IN 2021
    * NET LOSS FOR Q3 WAS $20.2 MILLION, COMPARED TO $11.8
MILLION FOR
SAME PERIOD IN 2021
    * Q3 REVENUE VIEW $34.8 MILLION -- REFINITIV IBES DATA
    * FY2022 REVENUE VIEW $132.3 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw9dqc6Pa 
Further company coverage:  CSTL.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Castle Biosciences

See all news